By Dr Brendan Clifford

Conference Abstracts

Clifford B; Ousley R; May R; Olsen N; Siefried K; Ezard N, 2025, 'Association Between Age of First Methamphetamine Use and Childhood Attention Deficit Hyperactivity Disorder Symptomatology—An Exploratory Study in a Clinical Trial Cohort', Sydney, Australia, presented at APSAD 2025 Conference, Sydney, Australia, 09 November 2025 - 12 November 2025, http://dx.doi.org/10.1111/dar.70014

Fletcher K; Freestone J; Clifford B; Ezard N; Kershaw S; Acheson L; Karavasilis T; Siefried K, 2025, 'Digital Health Interventions for People Who Use Methamphetamine: A Scoping Review', Sydney, Australia, presented at APSAD 2025 Conference, Sydney, Australia, 09 November 2025 - 12 November 2025, http://dx.doi.org/10.1111/dar.70014

Flood L; Clifford B; Siefried K; Fletcher K; Mazariego C; Karavasilis T; Karavasilis T, 2025, 'Evidence-Based Practice in the Australian Alcohol and Other Drug Workforce: A Cross-Sectional Survey', Sydney, Australia, presented at APSAD 2025 Conference, Sydney, Australia, 09 November 2025 - 12 November 2025, http://dx.doi.org/10.1111/dar.70014

Siefried K; Acheson L; Clifford B; Moller C; Brett J; Christmass M; Dunlop A; Haber P; Jutras-Aswad D; Lintzeris N; Morley K; Shoptaw S; Trivedi M; Ezard N, 2025, 'A Pilot Study of the Safety and Feasibility of Oral Naltrexone and Bupropion for Methamphetamine Use Disorder', Sydney, Australia, presented at APSAD 2025 Conference, Sydney, Australia, 09 November 2025 - 12 November 2025, http://dx.doi.org/10.1111/dar.70014

Acheson L; Macdonald H; Siefried K; Clifford B; Moller C; Brett J; Christmass M; Dunlop AJ; Haber P; Jutras-Aswad D; Lintzeris N; Morley KC; Shoptaw S; Trivedi M; Ezard N, 2025, 'Acceptability of Oral Naltrexone and Bupropion for Treatment of Methamphetamine Use Disorder', Sydney, presented at APSAD 2025 Conference, Sydney, 09 November 2025 - 12 November 2025, http://dx.doi.org/10.1111/dar.70014

Acheson L; Siefried K; Clifford B; Moller C; Brett J; Christmass M; Dunlop A; Haber P; Jutras-Aswad D; Lintzeris N; Morley KC; Shoptaw S; Trivedi M; Ezard N, 2025, 'Daily Smartphone Assessments for Substance Use Measurement in a Methamphetamine Clinical Trial', Sydney, Australia, presented at APSAD 2025 Conference, Sydney, Australia, 09 November 2025 - 12 November 2025, http://dx.doi.org/10.1111/dar.70014

Macdonald H; Kypri S; Clifford B; Siefried K; Ezard N; Freestone J, 2025, 'High-Dose MDMA Alerts at 150 Mg: Exploring the Utility and Appropriateness of Alert Thresholds', Sydney, Australia, presented at APSAD 2025 Conference, Sydney, Australia, 09 November 2025 - 12 November 2025, http://dx.doi.org/10.1111/dar.70014

Kypri S; Macdonald H; Broadbent E; Freestone J; Baird S; Clifford B; Siefried K; Ezard N; Gobeil J, 2025, 'High-Dose MDMA Pills, Heroin-Adulterated Stimulants and Nitazene Detections the Most Common Concerns; Reporting on Drug Alerts Issued in Australia for 2024', Sydney, Australia, presented at APSAD 2025 Conference, Sydney, Australia, 09 November 2025 - 12 November 2025, http://dx.doi.org/10.1111/dar.70014

Freestone J; Barratt M; Kypri S; Siefried K; Broadbent E; Macdonald H; Clifford B; Ezard N, 2025, 'Identifying Concerns and Collaborating for Rapid Response; Preliminary Findings From the Formative Evaluation of the Prompt Response Network', Sydney, Australia, presented at APSAD 2025 Conference, Sydney, Australia, 09 November 2025 - 12 November 2025, http://dx.doi.org/10.1111/dar.70014

Howes M; Zhou C; Kypri S; Ebdon E; Purcell L; Dessauer P; Beckers C; Chapman B; Weith S; Lamb M; Clifford B; Ezard N; Freestone J, 2025, 'Incorporating Lived-Living Experience Into Drug Monitoring Frameworks; Preliminary Insights From an Anecdotal Reporting System Co-Design Project', in Incorporating Lived-Living Experience Into Drug Monitoring Frameworks; Preliminary Insights From an Anecdotal Reporting System Co-Design Project, Sydney (Gadigal), Australia, presented at APSAD 2025 Conference, Sydney (Gadigal), Australia, 09 November 2025 - 12 November 2025, http://dx.doi.org/10.1111/dar.70014

Acheson L; Siefried K; Clifford B; Steele M; Fletcher K; Ezard N, 2025, 'People Seeking Treatment for Methamphetamine Use Are Getting Older and Treatment Services Need to Adapt', Sydney, Australia, presented at APSAD 2025 Conference, Sydney, Australia, 09 November 2025 - 12 November 2025, http://dx.doi.org/10.1111/dar.70014

Holman T; Middleton S; Slade D; Macdonald P; Lowe D; Watts GJ; Kennedy R; Clifford B; Patat L; Proctor R; Myhill B; Ng P; Goncharov L; Carr G; Straiton N, 2025, 'Assessing end-of-life care in cardiology wards within an Australian public hospital: a retrospective medical record audit', in EUROPEAN HEART JOURNAL, OXFORD UNIV PRESS, Vol. 46, http://dx.doi.org/10.1093/eurheartj/ehaf784.4077

Moller C; Siefried K; Clifford B; Acheson L; Brett J; Dunlop A; Haber P; Christmass M; Lintzeris N; Morley K; Shoptaw S; Trivedi M; Ezard N, 2023, 'Oral naltrexone-bupropion combination pharmacotherapy for methamphetamine use disorder: Pilot study protocol', in Drug and Alcohol Review, Wiley, Adelaide, Australia, Vol. 42, presented at The Australasian Professional Society on Alcohol and other Drugs Annual Scientific Conference, Adelaide, Australia, 12 November 2023 - 15 November 2023, http://dx.doi.org/10.1111/dar.13749

Clifford B; Shine P; Lo N; Stockwell T; Haber PS; Baldry E; Day CA; Dobbins T; Peacock A; Pauly B; Lintzeris N; Dolan K; Macklin B; Siefried KJ; Brett J; Dunlop AJ; Ezard N, 2022, 'The AusMAP study: A protocol for a randomised, controlled feasibility study of a managed alcohol program in Australia', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 41, pp. S44 - S45, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700078&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Acheson LS; Murray E; Clifford B; Siefried KJ; Matthews GV; Ezard N, 2019, 'OPTIMISING CARE FOR PEOPLE WHO INJECT DRUGS: A RETROSPECTIVE MEDICAL RECORD REVIEW OF STAPHYLOCOCCUS AUREUS BACTERAEMIA TREATMENT', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 38, pp. S22 - S23, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000494890100057&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Bruno R; Ezard N; Dunlop AJ; Clifford B; Carr A; Lintzeris N, 2017, 'COGNITIVE EFFECTS OF ESCALATING DOSES OF ORAL LISDEXAMFETAMINE IN METHAMPHETAMINE DEPENDENT ADULTS', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 36, pp. 23 - 23, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000424000500055&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ezard N; Webb B; Clifford B; Cecilio ME; Bruno R, 2017, 'DEVELOPMENT OF THE SUBSTANCE USE SEX INDEX - A NEW TOOL FOR BEHAVIOUR CHANGE MEASUREMENT IN DRUG TREATMENT STUDIES', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 36, pp. 31 - 31, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000424000500078&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Van Gordon K; Malone V; Magee F; Clifford B; Ezard N, 2016, 'BARRIERS TO STIMULANT TREATMENT ACCESS FOR WOMEN WHO USE METHAMPHETAMINE IN INNER SYDNEY: A QUALITATIVE STUDY', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 35, pp. 71 - 72, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398381500195&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ezard N; Dunlop AJ; Carr A; McKetin R; Ali R; White J; Bruno R; Dolan K; Clifford B; Lintzeris N, 2016, 'A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF LISDEXAMFETAMINE FOR THE TREATMENT OF METHAMPHETAMINE DEPENDENCE: THE LIMA STUDY PROTOCOL', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 35, pp. 35 - 36

Back to profile page